Literature DB >> 7690559

Preparation of a monoclonal antibody against rat MnSOD, using a COOH-terminal peptide.

F Ria1, M Landriscina, T Galeotti.   

Abstract

In the present paper we report the production of a monoclonal antibody against rat MnSOD, a supposed tumor-suppressor protein, using a purified synthetic peptide encompassing amino acids 184-198 to immunize mice, without conjugation to a carrier. The resulting antibody is able to recognize the native form of the protein, since it can immunoprecipitate the MnSOD activity in rat liver homogenate. In Western blot studies, the antibody recognizes a protein of 24 KD M(r), whose concentration varies according to the MnSOD activity and it apparently recognizes also human and mouse MnSODs. The protocol of immunization gives high yield of secreting lines. This monoclonal antibody will allow the detection of structural and functional alterations of MnSOD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690559     DOI: 10.1006/bbrc.1993.2101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin.

Authors:  M Landriscina; F Remiddi; F Ria; B Palazzotti; M E De Leo; M Iacoangeli; R Rosselli; M Scerrati; T Galeotti
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

2.  The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications.

Authors:  F Ria; M Landriscina; F Remiddi; R Rosselli; M Iacoangeli; M Scerrati; G Pani; S Borrello; T Galeotti
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.